Your browser doesn't support javascript.
loading
Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study.
Kelly, Kevin R; Ailawadhi, Sikander; Siegel, David S; Heffner, Leonard T; Somlo, George; Jagannath, Sundar; Zimmerman, Todd M; Munshi, Nikhil C; Madan, Sumit; Chanan-Khan, Asher; Lonial, Sagar; Chandwani, Suraj; Minasyan, Ashot; Ruehle, Markus; Barmaki-Rad, Farima; Abdolzade-Bavil, Afsaneh; Rharbaoui, Faiza; Herrmann-Keiner, Eva; Haeder, Thomas; Wartenberg-Demand, Andrea; Anderson, Kenneth C.
Afiliação
  • Kelly KR; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: kevin.kelly@med.usc.edu.
  • Ailawadhi S; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Siegel DS; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Heffner LT; Department of Hematology and Medical Oncology, Emory University - Winship Cancer Institute, Atlanta, GA, USA.
  • Somlo G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
  • Jagannath S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Zimmerman TM; BeiGene, Chicago, IL, USA.
  • Munshi NC; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Madan S; Banner MD Anderson Cancer Center, Phoenix, AZ, USA.
  • Chanan-Khan A; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Lonial S; Department of Hematology and Medical Oncology, Emory University - Winship Cancer Institute, Atlanta, GA, USA.
  • Chandwani S; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Minasyan A; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Ruehle M; Biotest AG, Dreieich, Germany.
  • Barmaki-Rad F; Biotest AG, Dreieich, Germany.
  • Abdolzade-Bavil A; Biotest AG, Dreieich, Germany.
  • Rharbaoui F; Biotest AG, Dreieich, Germany.
  • Herrmann-Keiner E; Biotest AG, Dreieich, Germany.
  • Haeder T; Biotest AG, Dreieich, Germany.
  • Wartenberg-Demand A; Biotest AG, Dreieich, Germany.
  • Anderson KC; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Lancet Haematol ; 8(11): e794-e807, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34529955
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Imunoconjugados / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Imunoconjugados / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article